ABT

Abbott Laboratories · BIVA:ABT

1,992.38 MXN−10.39 −0.52%

Abbott Laboratories (BIVA:ABT) last traded at 1,992.38 MXN, down 0.52% on the day. Over the past year the stock is down 14.61%. Its 52-week range is 1,413.00 to 2,364.00. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open1,967.46

Day range1,967.46 – 2,010.00

52-week range1,413.00 – 2,364.00

Volume27

Average volume (10 days)264

Market cap (USD)183.77 B

P/E40.67

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)−0.4600

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+3.93%1 week

+9.22%1 month

+5.34%3 months

+24.70%6 months

−11.93%Year to date

−14.61%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.